The expression of specific immunohistochemical markers (CD1a, langerin, and S100 protein) confirms the diagnosis of LCH on cytological samples, sparing a more invasive procedure such as transcranial biopsy. This evidence concerns the gene CD1A and Langerhans cell histiocytosis.